Position in JNJ
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$4,561,047
-$126,823 QoQ
Shares Held
17,959
-6.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#1,690
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Wellspring Financial Advisors, LLC holds $16,708,750 across 8 Drug Manufacturers - General names. JNJ ranks #1 (27.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
17,959 | $4,561,047 | |
| 2 | LLY |
ELI LILLY & Co
|
3,616 | $4,337,139 | |
| 3 | ABBV |
AbbVie Inc.
|
11,668 | $2,936,135 | |
| 4 | MRK |
Merck & Co., Inc.
|
22,465 | $2,886,752 | |
| 5 | AMGN |
Amgen Inc
|
1,927 | $697,805 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
4,213 | $532,270 | |
| 7 | PFE |
Pfizer Inc
|
21,099 | $508,063 | |
| 8 | AZN |
Astrazeneca PLC
|
1,316 | $249,539 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,561,047 | 17,959 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $4,687,870 | 19,178 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,703,577 | 17,896 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $3,016,968 | 16,271 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $2,385,496 | 15,617 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $2,542,990 | 15,334 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $3,900,401 | 26,970 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $4,494,896 | 27,736 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $4,123,758 | 28,214 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $6,515,213 | 41,186 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $6,465,838 | 41,252 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $6,744,909 | 43,306 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $7,491,931 | 45,263 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $7,154,335 | 46,157 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $8,412,426 | 47,622 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $7,711,082 | 47,203 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $8,409,358 | 47,374 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $8,473,543 | 47,811 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $8,251,048 | 48,232 | Shares | Sole | 2022-01-03 | |
| 2021-09-30 | $7,832,427 | 48,498 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $8,033,051 | 48,762 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $8,154,060 | 49,614 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $7,729,089 | 49,111 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $7,348,121 | 49,356 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $6,926,168 | 49,251 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $6,505,883 | 49,614 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||